Elinzanetant shows a strong safety profile with no liver toxicity and minimal side effects in menopausal women with vasomotor symptoms.
James A. Simon, MD, CCD, MSCP, IF, FACOG
Advertisement
James A. Simon, MD, CCD, MSCP, IF, FACOG, Clinical Professor of Ob/Gyn at George Washington University in Washington, DC.
Articles by James A. Simon, MD, CCD, MSCP, IF, FACOG
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Early estrogen use linked to lower disease risks
2
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
3
Clinical insights into vulvar health in menopause, with Melissa Mauskar, MD
4
Caroline Mitchell, MD, highlights safety and flexibility in treating GSM
5
